You are here: All Products  > CS Pharma Acquires China Rights to Fibrosis Drug in $336 Million Agreement

CS Pharma Acquires China Rights to Fibrosis Drug in $336 Million Agreement

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products